Scroll to the top

{{ subpage.title }}

What are the “known unknowns” about Moderna’s vaccine?
What Are the “Known Unknowns” About Moderna’s Vaccine? | Noubar Afeyan | GZERO World

What are the “known unknowns” about Moderna’s vaccine?

Moderna co-founder Noubar Afeyan concedes that there is plenty he still doesn't know about his company's COVID-19 vaccine, just as there's plenty he still doesn't know about the virus. But he is confident about one thing: "I view the vaccine as the best mask. It's a molecular mask, and once we have it onboard once, then presumably it will protect us." His conversation with Ian Bremmer was part of the latest episode of GZERO World.

Watch the GZERO World episode: A Shot in the Arm: Moderna's Co-Founder on the COVID-19 Vaccine

S. Korea sticks to flu vaccine plan as death toll rises to 48

October 25, 2020 5:00 AM

SEOUL • The number of South Koreans who have died after getting flu shots has risen to 48, the Korea Disease Control and Prevention Agency (KDCA) said yesterday, adding that the vaccines would continue to reduce the chance of having simultaneous epidemics.

South Korea sticks to flu vaccine plan after deaths rise to 48

October 24, 2020 10:20 PM

"It is not the time to suspend a flu vaccination programme,” KDCA Director Jeong Eun-kyung said.

Asian countries step up flu shots to avert complications

September 15, 2020 5:00 AM

TOKYO/SEOUL/BEIJING • Some Asian countries are rolling out early and more aggressive influenza vaccination programmes this year, seeking to reduce the potential of people contracting the flu and Covid-19 simultaneously and crippling healthcare systems.

Death toll exceeds 200 in Australia's flu season

June 30, 2019 5:00 AM

CANBERRA • The death toll from Australia's flu season has passed 200, with the authorities warning that the worst is yet to come.

Over 200 dead as Australia braces for peak flu season

June 29, 2019 2:45 PM

CANBERRA (XINHUA) - The death toll from Australia's flu season has passed 200, with authorities warning that the worst is yet to come.

Subscribe to our free newsletter, GZERO Daily

Latest